Science Market Update

UC San Diego Receives Two, $2M Research Grants from CIRM

Posted by Rebecca Partridge on Mon, Feb 20, 2017

 

The California Institute for Regenerative Medicine (CIRM) awarded two scientists at UC San Diego $2 million each for their innovative research. The first award went to Alysson R. Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine. The funding will support studies of new treatments for Zika. The second award went to Dan Kaufman, MD, PhD, professor of medicine in the Division of Regenerative Medicine. This funding will support the creation an “off-the-shelf immunotherapy” using NK cells to treat refractory or resistant tumors, such as ovarian cancer.

Read More

Tags: Bioresearch funding, Cancer Treatment, Cancer, Biotechnology Vendor Fair, UCSD, UC San Diego, CIRM, research grants, zika, Biotechnology trade show

$2.27M Research Grant to University of Georgia, Athens to Study Gene Editing

Posted by Rebecca Partridge on Wed, Feb 15, 2017

The National Institute of Health (NIH) awarded the University of Georgia a $2.27 Million grant to study a powerful gene editing tool known as CRISPR-Cas. In nature, CRISPR-Cas is a defense mechanism that single-celled organisms such as bacteria use to ward off attacks from viruses and other invaders. For scientists the CISPR-Cas9 system holds a potential tool to edit precise sequences of DNA and silence the genes that predispose some people to diseases such as cancer, diabetes, cardiovascular disorders and mental illness.

Read More

Tags: biomedical research, University of Georgia Athens, University of Georgia, DNA Research, UGA, Biotechnology Vendor Fair, Biotechnology trade show

Emory Research Lab Event: 2X Researchers Expected

Posted by BCI Staff on Tue, Feb 14, 2017

18th Annual
Read More

Tags: Emory, GA, lab event

UCLA: Utilizing Patient's Own Cells for Individualized Stem Cell Therapies

Posted by Rebecca Partridge on Wed, Feb 08, 2017

Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.

Read More

Tags: University of California Los Angeles, Stem cell research, Human Stem Cell, UCLA, Stem Cell, biotech vendor show, Biotechnology trade show

Rockefeller Receives $25M to Turn Discoveries into Therapies

Posted by Rebecca Partridge on Mon, Feb 06, 2017

Rockefeller University received a $25 million gift from the Robertson Foundation that will be used to create the Robertson Therapeutic Development Fund. This fund will be used to help turn basic research discoveries into new medical therapies by providing support for dozens of Rockefeller projects over the next five years. Research grants ranging from $10,000 to $1 million will be awarded from the fund in order to provide Rockefeller scientists with the resources they need to take exceptionally promising research initiatives through the steps that lead to breakthrough medications, new diagnostic tests or other clinical innovations.

Read More

Tags: Rockefeller University, Bioresearch funding, Biotech Event, new research funding, Biotechnology Vendor Fair, Research Funding, Rockefeller, research news, Biotechnology trade show

UCR Life Science Study Uncovers Fruit Fly Metamorphosis Trigger

Posted by BCI Staff on Fri, Jan 27, 2017

Next week PLOS journal will publish an exciting article featuring a new biological discovery. Scientists at UC Riverside have discovered critical information regarding insect development.

This study uncovers the use of DNA as an organism’s biological clock in sexual development, or metamorphosis in insects. With applications in new cancer treatments, agriculture, human health and potential applications in zoology, this study opens gateways of undiscovered information. This is one exciting example of the potential in research and the intersectionality in life science, molecular biology and biotechnology supplies.


Read More

Tags: CA, agriculture, DNA Research, Cancer, Genome, UCR, Fruit Fly

Washington University, St. Louis Leading Drug Trial for Alzheimer's Prevention

Posted by Rebecca Partridge on Tue, Jan 24, 2017

Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”

Read More

Tags: Washington University St. Louis, Washington University, WUSTL, Alzheimer' Research, Alzheimer’s, Research Funding, biotech vendor show, Alzheimer's treatment market, Bioresearch Grant, Biotechnology trade show

Two New Mass Spectrometers Make Texas A&M a Top Facility for Studying Isotopes

Posted by Rebecca Partridge on Thu, Jan 19, 2017

The chancellor’s office of Texas A&M University (TAMU) recently funded a $5 million initiative to support mass spectrometry research. As part of this initiative a $1 million grant from the Texas A&M University Research Development Fund will be used to develop a shared mass spectrometry core facility and buy two new mass spectrometers for the College Station campus. One will be a gas chromatography combustion/pyrolysis isotope ratio mass spectrometer and the other will be a high resolution isotope ratio mass spectrometer for clumped isotopes.

Read More

Tags: TAMU, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment

Texas Medical Center Pioneers New Brain Cancer Treatment

Posted by Rebecca Partridge on Wed, Jan 18, 2017

Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.

Read More

Tags: cancer research, Texas Medical Center, Cancer, tmc, Biotechnology Vendor Fair, cancer therapy, Bioresearch Grant, Biotechnology trade show

$2.5M to USF to Study Licensing of Parasites

Posted by Rebecca Partridge on Tue, Jan 17, 2017

Malaria and toxoplasmosis are caused by different, yet closely related, apicomplexa parasites.  Efforts to eliminate these diseases have met with only partial success. Now the National Institute of Health (NIH) has awarded the University of South Florida (USF) a $2.5 million, five year grant to study a new approach to fighting these diseases by stopping their ability to replicate.

Read More

Tags: BioResearch Trade Show, malaria, Research Funding, parasite, University of South Florida, USF, Bioresearch Grant

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!